Cybin seeks to build an international footprint via scaling up activities in Europe with its Ireland subsidiary, including the transfer of its IP assets.

After a half century spent waging war on drugs, Americans seem ready to sue for peace.

The White House’s drug policy arm is looking for input on whether its existing policies are creating “systemic barriers to opportunities for underserved communities” and whether future programs could be developed to better promote equity.

The emerging psychedelic drug sector represents the most lucrative opportunities in life sciences today. We compare and contrast six of the drug R&D leaders.

It turns out, psychedelic mushroom trips may change your life.

A study published in the International Journal of Drug Policy asked psychedelic drug users to share their experiences with drug use, and particularly, their experiences with “bad trips.”

Portions of the legislature-approved legalization laws in Connecticut and Virginia take effect today including possession and use for adults 21-and-older in both states.

Despite their illegality and a tendency among the media and politicians to demonize their use, psychedelics have been shown to have transformative effects on individuals suffering from mental health problems, including depression and anxiety.

Earlier this year in April, the Colorado Department of Public Health and Environment released a publication that included changes to state “wholesale food, industrial hemp and shellfish regulations.”

Compass Pathways completes the world’s largest psilocybin-based clinical trial as the 216th patient in its trial completed their treatment.